Undifferentiated Undifferentiated is a pathological type of nasopharyngeal carcinoma, which belongs to type III in WHO staging, and is only likely to achieve clinical cure, with a five-year survival rate of about 65%.
Undifferentiated non-keratinized nasopharyngeal carcinoma is a malignant tumor and is sensitive to radiotherapy. If patients are actively treated, they can usually effectively control the disease, prolong the survival time and improve the quality of life. If patients with undifferentiated non-keratinized nasopharyngeal carcinoma do not follow the medical advice, the prognosis is poor.
Clinical treatment for undifferentiated non-keratinized nasopharyngeal carcinoma is mainly through radiotherapy, and some patients can also be treated with chemotherapy such as nitrogen mustard, cyclophosphamide, 5-fluorouracil, bleomycin, and septifibatide according to medical advice.
Surgical resection and cervical lymph node dissection are suitable for patients with limited lesions in nasopharynx that do not subside or recur after radiotherapy, and cervical lymph node dissection is suitable for patients with metastatic lymph nodes in the neck that do not subside after radiotherapy, showing an active and isolated mass, and whose nasopharyngeal primary foci have been controlled.
Patients with undifferentiated non-keratinized nasopharyngeal cancer should adjust their mindset and actively treat under doctor’s guidance. Attention should be paid to regular medical checkups in order to monitor the changes of the condition and adjust the treatment plan in time.